Carregant…

Correction: Lalani, S. and Poh, C.L. Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71). Viruses 2020, 12, 184

Dades bibliogràfiques
Autors principals:	Lalani, Salima, Poh, Chit Laa
Format:	Online Article Text
Idioma:	English
Publicat:	MDPI 2020
Matèries:	Correction
Accés en línia:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412425/ https://www.ncbi.nlm.nih.gov/pubmed/32630136 http://dx.doi.org/10.3390/v12070712

Ítems similars

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
per: Lalani, Salima, et al.
Publicat: (2020)

Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
per: Lalani, Salima, et al.
Publicat: (2021)

Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71)
per: Masomian, Malihe, et al.
Publicat: (2021)

Antiviral activity of silymarin in comparison with baicalein against EV-A71
per: Lalani, Salima S., et al.
Publicat: (2020)

Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease
per: Lalani, Salima, et al.
Publicat: (2021)

Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
per: Tan, Chee Wah, et al.
Publicat: (2012)

Development of Novel Vaccines against Enterovirus-71
per: Yee, Pinn Tsin Isabel, et al.
Publicat: (2015)

T Cell Immunity To Enterovirus 71 Infection In Humans And Implications For Vaccine Development
per: Yee, Pinn Tsin Isabel, et al.
Publicat: (2018)

Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence
per: Mandary, Madiiha Bibi, et al.
Publicat: (2018)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
per: Lim, Hui Xuan, et al.
Publicat: (2019)

Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71
per: Yee, Pinn Tsin Isabel, et al.
Publicat: (2016)

Characterization of Plaque Variants and the Involvement of Quasi-Species in a Population of EV-A71
per: Mandary, Madiiha Bibi, et al.
Publicat: (2020)

Insights into In Vitro Adaptation of EV71 and Analysis of Reduced Virulence by In Silico Predictions
per: Koh, Jia Xuen, et al.
Publicat: (2023)

Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers
per: Tan, Chee Wah, et al.
Publicat: (2014)

Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection
per: Rattanapisit, Kaewta, et al.
Publicat: (2019)

Corrigendum to “Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers” [Antiviral Res. 107 (2014) 35–41]
per: Tan, Chee Wah, et al.
Publicat: (2014)

Construction of an infectious cDNA clone of Enterovirus 71: Insights into the factors ensuring experimental success
per: Lazouskaya, Natallia V., et al.
Publicat: (2014)

Protective effect of enterovirus-71 (EV71) virus-like particle vaccine against lethal EV71 infection in a neonatal mouse model
per: CAO, LEI, et al.
Publicat: (2015)

Both ERK1 and ERK2 Are Required for Enterovirus 71 (EV71) Efficient Replication
per: Zhu, Meng, et al.
Publicat: (2015)

Antivirals and vaccines for Enterovirus A71
per: Lin, Jing-Yi, et al.
Publicat: (2019)

Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice
per: Dai, Wenwen, et al.
Publicat: (2019)

Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
per: Victorio, Carla Bianca Luena, et al.
Publicat: (2014)

Correction: Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
Publicat: (2014)

Enterovirus 71 Outbreak, Brunei
per: AbuBakar, Sazaly, et al.
Publicat: (2009)

Strategies to develop antivirals against enterovirus 71
per: Kuo, Rei-Lin, et al.
Publicat: (2013)

The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro
per: Li, Xiang, et al.
Publicat: (2015)

Antiviral activity of micafungin against enterovirus 71
per: Kim, Chonsaeng, et al.
Publicat: (2016)

A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema
per: Victorio, Carla Bianca Luena, et al.
Publicat: (2016)

Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication
per: Gao, Wenying, et al.
Publicat: (2020)

Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
per: Yee, Pinn Tsin Isabel, et al.
Publicat: (2019)

An infectious clone of enterovirus 71(EV71) that is capable of infecting neonatal immune competent mice without adaptive mutations
per: Zhang, Huiying, et al.
Publicat: (2020)

Antivirals blocking entry of enteroviruses and therapeutic potential
per: Anasir, Mohd Ishtiaq, et al.
Publicat: (2021)

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71
per: Wang, Xiangxi, et al.
Publicat: (2012)

Antiviral Effect of Matrine against Human Enterovirus 71
per: Yang, Yajun, et al.
Publicat: (2012)

Developments towards antiviral therapies against enterovirus 71
per: Wu, Kan X., et al.
Publicat: (2010)

Enterovirus A71 antivirals: Past, present, and future
per: Wang, Jun, et al.
Publicat: (2022)

Receptors for enterovirus 71
per: Yamayoshi, Seiya, et al.
Publicat: (2014)

Enterovirus71 (EV71) Utilise Host microRNAs to Mediate Host Immune System Enhancing Survival during Infection
per: Lui, Yan Long Edmund, et al.
Publicat: (2014)

A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity
per: Li, Bingqing, et al.
Publicat: (2017)

Interaction between PHB2 and Enterovirus A71 VP1 Induces Autophagy and Affects EV-A71 Infection
per: Su, Weitao, et al.
Publicat: (2020)

Cannot write session to /tmp/vufind_sessions/sess_32nek2ponfb6e0fdkbrmsirm5n